Symbol
|
YERLTQ | Z08TSZ | 0932BC | RMAR2V | OOZRCH |
---|---|---|---|---|---|
Nom | Barrier Reverse Convertible | Multi Barrier Reverse Convertible | Barrier Reverse Convertible | Callable Multi Defender Vonti | Worst of Reverse Convertible |
Sous-jacent
|
Abbott Laboratories / Bristol-Myers Squibb Co. / Roche AG | Abbott Laboratories / Eli Lilly & Co. / Merck & Co. Inc. | Abbott Laboratories / Alcon / UnitedHealth Group Inc. | Abbott Laboratories / ABBVIE Inc. / Eli Lilly & Co. | Abbott Laboratories / Eli Lilly & Co. / Merck & Co. Inc. |
Emetteur
|
![]() |
![]() |
![]() |
![]() |
![]() |
Échéance
|
04.04.2025 | 13.12.2024 | 19.03.2025 | 15.12.2025 | 22.01.2026 |
Demande | 96,57 | 103,27 | 101,41 | 100,60 | 95,96 |
Offre | 97,37 | 103,77 | 102,21 | 101,40 | 96,76 |